Vedana Therapeutics
PrivateLast Round
Series A
Jun 17, 2026
Total Funding Raised
$46M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Vedana Therapeutics operates in Healthcare & Life Sciences and is based in Seattle, Washington. Its latest recorded funding round was a Series A round in June 2026.
Vedana Therapeutics is a biotechnology company that develops next-generation therapies for migraine prevention.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vedana Therapeutics Comparables
Compare Vedana Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Slate Medicines | 94% | |
| DartsBio Pharmaceutical (Guangdong) Co., Ltd. | 78% | |
| H. Lundbeck A/S | 71% |
For institutional investors. Book with your work email.
Vedana Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Vedana Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Westlake Village BioPartners | Series A |
| Canaan Partners | Series A |
| Alexandria Venture Investments | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2026
$46M round led by Canaan Partners and Westlake Village Biopartners.
For institutional investors. Book with your work email.
Vedana Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Vedana Therapeutics's valuation, stock price, and market status.
Is Vedana Therapeutics a public or private company?
Vedana Therapeutics is a private company.
What is the current stock price of Vedana Therapeutics?
Vedana Therapeutics is a private company, so its shares have no public market price. Caplight tracks Vedana Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Vedana Therapeutics worth (valuation)?
Valuation information for Vedana Therapeutics is not publicly available.
Can I buy Vedana Therapeutics stock?
Vedana Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Vedana Therapeutics's last funding round?
Vedana Therapeutics's most recent funding round was Series A on June 17, 2026.
Who are the main investors in Vedana Therapeutics?
Key investors in Vedana Therapeutics include Westlake Village BioPartners, Canaan Partners.
Will Vedana Therapeutics IPO soon?
No public IPO plans have been announced for Vedana Therapeutics.
How can I track Vedana Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Vedana Therapeutics's shares on secondary markets.